Genome editing: CRISPR – Cas becoming more human

Nature Reviews Molecular Cell Biology 18, 591 (2017).
doi:10.1038/nrm.2017.84

Author: Kim Baumann
CRISPR–Cas9 was used in human embryos to correct a dominant heterozygous gene mutation that causes hypertrophic cardiomyopathy.

Source: Nature Reviews Molecular Cell Biology - August 16, 2017 Category: Cytology Authors: Kim Baumann Tags: Research Highlight Source Type: research